Related Experiment Video
Updated: Feb 28, 2026
08:36
The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.5K
Utilizing an Augmented Reality Headset to Accurately Quantify Lower Extremity Function in Parkinson's Disease.
Andrew Bazyk1, Colin Waltz2, Ryan D Kaya1
1Center for Neurological Restoration, Neurological Institute, Cleveland Clinic, 9500 Euclid Ave., Cleveland, OH 44195, USA.
Sensors (Basel, Switzerland)
|February 27, 2026
Summary
Markerless motion capture (MMC) offers objective gait analysis for Parkinson's disease (PD). A new algorithm (CART-MMC) accurately measures lower extremity function, aiding in PD diagnosis and treatment monitoring.
Area of Science:
- Biomedical Engineering
- Neuroscience
- Rehabilitation Technology
Background:
- Subjective gait assessments limit Parkinson's disease (PD) treatment.
- Markerless motion capture (MMC) can provide objective biomechanical data.
- Validation is crucial for clinical adoption of MMC in PD.
Purpose of the Study:
- Evaluate the criterion validity of a custom MMC algorithm (CART-MMC) against 3D motion capture.
- Assess CART-MMC's ability to differentiate PD patients from healthy controls (HC).
- Determine the clinical utility of CART-MMC for lower extremity function in PD.
Main Methods:
- Sixty-two individuals with PD and 29 HCs performed a stepping in place task.
- Data collected using an augmented reality headset with RGB and depth cameras.
- CART-MMC algorithm computed 3D pose and biomechanical measures, compared to traditional 3D motion capture.
Main Results:
- CART-MMC outcomes were statistically equivalent (within 5%) to traditional 3D motion capture for step count, cadence, duration, height, asymmetry, and path length.
- CART-MMC identified significant differences between PD and HC groups in step height, variability, asymmetry, duration variability, and normalized path length.
Conclusions:
- The CART-MMC algorithm provides valid biomechanical measures of lower extremity function in PD.
- Validated MMC tools can track disease progression and monitor treatment efficacy.
- Objective biomechanical evaluation supports personalized PD therapy and clinical decision-making.
